Repatha 140 MG/ML sureclickml
Ended Awarded Last action
- Contract number
- SPE2DR26FM6E4
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $42,566
Award facts
- Contract value 100% obligated
- $42,565.72 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $42,565.72 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors, with an ultimate completion date of December 10, 2025. This non-competitive delivery order was issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vendor agreement running through December 2026 that enables the company to supply pharmaceuticals and medical supplies globally to support military healthcare programs. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting the Defense Health Agency and other military and veteran healthcare systems.
Repatha (evolocumab) is a PCSK9 inhibitor prescribed for high cholesterol management, and this order reflects the military's medical supply needs for cardiovascular disease treatment. The delivery order represents a typical transaction under AmerisourceBergen's comprehensive pharmaceutical supply agreement with DLA, which covers a diverse range of therapeutic products from specialty medications to vaccines and medical devices. As a competitively awarded prime contract with no set-aside designation, this delivery order demonstrates AmerisourceBergen's continued capability to fulfill federal pharmaceutical procurement requirements through open competition.
Quick answers
Who was awarded contract SPE2DR26FM6E4?
SPE2DR26FM6E4 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 9, 2025.
How much is contract SPE2DR26FM6E4 worth?
The government has obligated $42,566 on SPE2DR26FM6E4.
Is contract SPE2DR26FM6E4 an order under another contract?
Yes. SPE2DR26FM6E4 is a delivery order under SPE2DR25D2211, an indefinite delivery contract.
Was contract SPE2DR26FM6E4 competed?
The extent of competition for SPE2DR26FM6E4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award